Zacks Investment ResearchTue, 19 May 2026 16:26:24 GMTTeva Stock Up More Than 100% in a Year: Time to Buy, Hold or Sell?SNY-0.08%
Seeking AlphaMon, 11 May 2026 15:08:22 GMTSanofi: Great Yield And Plenty Of Upside PotentialSNY-0.08%
Zacks Investment ResearchFri, 08 May 2026 17:41:31 GMTDNLI Q1 Loss Narrower Than Expected, Avlayah Approval Boosts ProspectsSNY-0.08%
Zacks Investment ResearchThu, 23 Apr 2026 17:46:21 GMTSNY's Tzield Gets FDA Nod for Kids, Sarclisa SC BLA Faces DelaySNY-0.08%
Zacks Investment ResearchThu, 23 Apr 2026 14:20:25 GMTSanofi Tops Q1 Earnings Estimates as Dupixent & New Drugs Drive GrowthSNY-0.08%
Investors Business DailyThu, 23 Apr 2026 12:54:21 GMTSanofi Leans On Dupixent For First-Quarter Beat A Week Ahead Of New CEOSNY-0.08%
Zacks Investment ResearchTue, 07 Apr 2026 17:01:35 GMTSNY's Lunsekimig Succeeds in Asthma & CRSwNP Studies, Fails in EczemaSNY-0.08%
Zacks Investment ResearchTue, 31 Mar 2026 17:16:10 GMTSanofi Gets EU Nod for Rezurock in Chronic Graft-Vs-Host DiseaseSNY-0.08%
Zacks Investment ResearchTue, 03 Mar 2026 16:01:12 GMTSanofi's Wayrilz Gets Orphan Drug Tag for IgG4-Related Disease in JapanSNY-0.08%
